Chlamydia pneumoniae DNA is more frequent in advanced than in mild atherosclerosis lesions

Ahmad Reza Bahrmand1, Moslem Bahadori, Abdolmajid Hossaini

  • 1Pasteur Institute of Iran, Tehran, Islamic Republic of Iran. padideh79@yahoo.com

Insights

Chlamydia pneumoniae DNA was detected in arterial specimens, suggesting its role in atherosclerosis development, particularly in older individuals lacking traditional risk factors. This finding highlights a potential link between infection and cardiovascular disease.

Area of Science:

  • Infectious Diseases
  • Cardiovascular Pathology
  • Molecular Biology

Background:

  • Atherosclerosis is a complex disease with multifactorial origins.
  • The role of infectious agents, such as Chlamydia pneumoniae, in atherosclerosis pathogenesis is under investigation.
  • Understanding novel contributing factors is crucial for effective disease prevention and treatment.

Purpose of the Study:

  • To investigate the presence of Chlamydia pneumoniae in human arterial tissues.
  • To explore the association between C. pneumoniae infection and the severity of atherosclerotic lesions.
  • To examine the relationship between C. pneumoniae detection and traditional cardiovascular risk factors.

Main Methods:

  • Polymerase chain reaction (PCR) was employed to detect C. pneumoniae DNA in arterial specimens.
  • Specimens were obtained from autopsy cases with cardiac death and patients undergoing vascular surgery.
  • Control specimens from normal pulmonary arteries were analyzed.

Main Results:

  • C. pneumoniae DNA was detected in 17% of severe atherosclerotic lesions versus 3% of mild lesions (p < 0.01).
  • Overall, 28% of cases tested positive for C. pneumoniae in vascular samples, with 86% of these being aged 60 or older.
  • PCR-positive cases had lower LDL cholesterol and triglyceride levels and fewer traditional risk factors compared to PCR-negative cases (p < 0.05).

Conclusions:

  • The findings support a potential role for Chlamydia pneumoniae in human atherosclerosis development.
  • C. pneumoniae may contribute to atherosclerosis, especially in cases where conventional risk factors are not apparent.
  • This suggests C. pneumoniae as a potential target for further research in cardiovascular disease etiology.

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...